Apalutamide Recruiting Phase 3 Trials for Adenocarcinoma, Prostate / Biochemically Recurrent Prostate Carcinoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04423211Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Using PET/CT Imaging